Barron's Stem Cell Stocks
9156 views
Rate Now: 1 2 3 4

average rating: 3.00 / 4 ratings
Created by Barrons
DESCRIPTION:

Date updated:05-05-2007

From Barron's 5-7-07

"If wall street believes in following the money, much of its own private cash has gone to stem cells lately (see Wealthy Individuals, States Fund What Bush Won't). And private-equity money could well follow as the science gathers momentum. "There's a whole developing field of socially responsible investing, and I think it hasn't yet looked at critically necessary medicine," says Robert Klein, the real-estate developer who was the driving force behind California's decision to fund stem-cell research. Within three years, more money should come from venture-capital investors, pensions with a social mandate, and the growing pool of socially responsible funds, Klein says."

symbol name last price % change open
  • +
  • GENZ
    Genzyme Corporati
  • $51.07
  • -0.87%
  • $50.58

"Genzyme's (GENZ) stance, for one, is fairly typical of big biotech's. The Cambridge, Mass., company is no stranger to cell-based treatment and therapy, having explored the field for more than a decade. "Cell and gene therapy in the last 20 years has tended to over-promise and under-deliver," says John McPherson, head of its biologic research. Still, Genzyme says it continues to study the field, and this includes watching for small promising companies to buy."

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: C+ What is this?

  • +
  • MRK
    Merck Co Inc
  • $36.29
  • -0.77%
  • $35.98

"Merck (MRK) has provided funding in exchange for shares -- with warrants to buy more -- in Geron (GERN), a Menlo Park, Calif., biotech company that works with embryonic stem cells."

People owning MRK also tend to own: CCATDEFNMFREGEKO

TheStreet.com Rating: B- What is this?

  • +
  • BSX
    Boston Scientific
  • $8.50
  • -1.62%
  • $8.35

"Boston Scientific (BSX), which makes the nation's top-selling drug-coated heart stent, has a joint venture with Osiris to develop its stem-cell treatment for heart disease."

People owning BSX also tend to own: OSIPOSTKAOGHALSTYCCTB

TheStreet.com Rating: D+ What is this?

  • +
  • GE
    Gen Electric Co
  • $15.94
  • -1.48%
  • $15.49

"General Electric's (GE) health-care unit has acquired exclusive global rights to distribute a device from ThermoGenesis (KOOL) that extracts and stores stem cells"

People owning GE also tend to own: AIGAXPDELLIBMINTCMSFTAAPL

TheStreet.com Rating: C What is this?

  • +
  • OSIR
    Osiris Therapeuti
  • $6.61
  • +1.69%
  • $6.46

"Provacel stem-cell treatment for heart disease."

People owning OSIR also tend to own: CHKCHTRIDTIGOMRIPFEPPHM

TheStreet.com Rating: E+ What is this?

  • +
  • VIAC
    Viac
  • $0.00
  • N/A
  • $N/A

"Cord-blood stem-cell treatment for cardiac disease."

People owning VIAC also tend to own: ACTC.OBALXNARIAASTMCELGCRISDNDN

TheStreet.com Rating: No Rating What is this?

  • +
  • KOOL
    Thermogenesis Cor
  • $0.6011
  • -1.62%
  • $0.6175

"Distribution of device for extracting/storing stem cells."

People owning KOOL also tend to own: NWSSUNHACTC.OBALXNARIAASTM

TheStreet.com Rating: D What is this?

  • +
  • CYTX
    Cytori Therapeuti
  • $5.15
  • +4.25%
  • $4.74

"Make device for extracting stem cells from cord blood."

People owning CYTX also tend to own: ABPATICMGICVAFRPTKYPHMER

TheStreet.com Rating: E+ What is this?

  • Page 1 of 2
  • 1
  • 2
previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

latest articles | popular forums
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to Jim Cramer, investors need to know the four enemies of all bull markets. On Wednesday’s “Mad Money” TV show...

11.27.09 | 13:36 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 27, 2009 According to CNBC’s “Fast Money” traders, the adjustment in the third-quarter GDP figure released on Tuesday from an exp...

11.27.09 | 12:22 PM
Black Friday Short-Squeeze Oppor...

By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...

11.25.09 | 13:33 PM
Dividend Stocks for the Week

By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...

11.24.09 | 11:36 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Other People's Ideas (OPI)
11.28.09 | 15:23 PM From author Valerie J
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
more forums
recent answers | popular answers
bubble(3)
Q. Stockpickrs: if you get 6%/mo tr...
11.29.09 | 14:19 PM Asked by ksh

A. i was a fundie trader until last summer
when that stopped working. been learning
ta since. rate of return depends on when
you want to start counting. sure isn't
anywhere near 72%/yr. i'm a individual
investor. i use etf's probably in 15% of
my trades, most of the time for 1 to 10
days. if you don't know ta yet, i urge
you to take the time to learn it.
there's a lot of it to learn, but it
works. mike

show all recent stockpickr answers
today 's lists
Dogs of the Dow

Here are the 10 stocks in the Dow Jones Industrial Average stocks with the highest yields as of the market close on June 2, 2009. more

Cramer's Lightning Round

These are the stocks from Jim Cramer's Nov. 24 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more

TheStreet.com TV Videos

These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more

show all today's lists